How is bevacizumab typically given (administered)?
Bevacizumab is administered into a vein (intravenous) and the dose depends on several factors, including the condition being treated, the size of the patient, the particular regimen being used, and the overall health of the patient. Bevacizumab therapy should not be initiated for at least 28 days following major surgery and the surgical incision should be fully healed prior to initiation of therapy.How are patients monitored? Patients will usually have scheduled meetings with their healthcare provider while they are being treated with bevacizumab. Patients may undergo physical examination, scans or other measures to assess side effects and response to therapy. Patients will be monitored during the infusion for signs of an allergic reaction and changes in blood pressure. In addition, patients may be closely monitored for abdominal pain, nausea, vomiting, constipation, or coughing up of blood, as these could be symptoms of abdominal hemorrhage or gastrointestinal performation. Patients m
